Project Grant R61MH138647
Award Date
4/1/25
Completion Date
3/31/27
Dollars Obligated
$969K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The University of California, San Diego (UCSD) was awarded a $1,683,984 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The grant, titled "Mindfulness Engaged Neurostimulation for Depression (MEND)," aims to develop a multimodal neurotherapeutic strategy for treating depression by pairing digital breath attention training with repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral...
This $107,948 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will leverage ultra-high field magnetic resonance imaging (MRI) to elucidate the glutamatergic mechanisms underlying repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depressive disorder (MDD). The overarching goal is to provide unprecedented mechanistic insights into how rTMS alters glutamate signaling and functional...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, will fund a study to investigate cortical inhibition as a biomarker for response to bilateral versus unilateral accelerated theta burst stimulation (ATBS) for suicidal ideation in treatment-resistant depression. The $197,576 award to the University of California, San Diego (UCSD) will support a randomized, double-blind clinical trial over 5 years to test...
The National Institute of Mental Health (NIMH) awarded a $1,377,361 Cooperative Agreement under the Mental Health Research Grants program (CFDA 93.242) to Weill Medical College of Cornell University. The project aims to develop and validate a biomarker-guided approach for selecting between two highly effective treatments for treatment-resistant depression (TRD) - accelerated repetitive transcranial magnetic stimulation (rTMS) and ketamine. The research will leverage machine learning methods...
This $156,500 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support a study to identify patients with true treatment failure for major depressive disorder (MDD) who may benefit from earlier referral to alternative therapies such as transcranial magnetic stimulation, ketamine, and vagus nerve stimulation. The study will use trajectory classification methods on clinical trial and real-world data to...
The National Institute of Mental Health (NIMH) awarded a $967,781 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of Utah to evaluate the potential of a novel, non-invasive ultrasonic neuromodulation device for treating treatment-resistant depression.
The project aims to demonstrate the device's ability to precisely stimulate deep brain circuits and modulate mood symptoms in individuals with treatment-resistant depression. The R61 phase will assess the intensity...
The National Institute of Mental Health (NIMH) awarded a $182,528 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop and evaluate a novel approach using multifocal transcranial magnetic stimulation (TMS) combined with electroencephalography (EEG) to modulate and study brain network connectivity in individuals with major depressive disorder. The four-year project (Sep 2024 - Aug...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $898,025 to the University of Cincinnati to evaluate the use of transcutaneous spinal direct current stimulation (tsDCS) as a tool to modulate spinal interoceptive pathways (SIPS) and assess their role and therapeutic potential in treating major depressive disorder (MDD) symptom domains.
The grant funds a two-phase R61/R33 study that first aims...
This is a Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The $830,409 award to Brigham & Women's Hospital will fund the development of novel software and computational techniques that integrate real-time navigated electric-field mapping and source-space electroencephalogram (EEG) analysis during transcranial magnetic stimulation (TMS) to improve the accuracy of targeting and dosimetry for...
This $2,263,752 Project Grant was awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The grant aims to determine whether and how transcranial magnetic stimulation (TMS) of the dorsolateral prefrontal cortex (DLPFC) can modulate the activity of the amygdala, a key brain region involved in psychiatric disorders. The research will utilize a combination of invasive intracranial electroencephalography (iEEG) in epilepsy patients...